Fanny Boisleve , Hind Assaf Vandecasteele , James Baily , Kamil Czuchrowski , Malik Diop , Catherine Gadras , David Herbst , Christina Hickey , Amaia Irizar , Boris P. Müller , Nikaeta Sadekar , Paul Sterchele , Matthias Vey , Nicola J. Hewitt
{"title":"Use of NAMs in a weight of evidence approach to evaluate the safety via the inhalation route of acetylated vetiver oil, in spray products","authors":"Fanny Boisleve , Hind Assaf Vandecasteele , James Baily , Kamil Czuchrowski , Malik Diop , Catherine Gadras , David Herbst , Christina Hickey , Amaia Irizar , Boris P. Müller , Nikaeta Sadekar , Paul Sterchele , Matthias Vey , Nicola J. Hewitt","doi":"10.1016/j.yrtph.2025.105905","DOIUrl":null,"url":null,"abstract":"<div><div>Acetylated Vetiver Oil (AVO) is a fragrance ingredient. We evaluated the systemic and local toxicity of AVO via inhalation from use of cosmetic spray products.</div><div>Systemic exposure after inhalation was calculated using a deterministic 2-Box model. The “local inhalation toxicological threshold of concern” (TTC<sub>inh</sub>) was used in a weight of evidence (WoE) for the potential of AVO to cause local respiratory toxicity and the <em>in vitro</em> model, MucilAir™ was used to evaluate respiratory irritation.</div><div>AVO exposure by inhalation of sprayed cosmetic products does not add significant exposure compared to dermal exposure. The Margin of Safety (NOAEL compared to total systemic AVO exposure) is > 400, indicating no concern for systemic toxicity. Regarding local toxicity, total aggregate exposure to AVO in sprayable cosmetic products is significantly lower than the TTC<sub>inh</sub>. There were no injurious effects to MucilAir™ tissues by 0.2 % and 1 % AVO. When the NOAEL from the MucilAir™ assay (1 %) and the aggregated exposure were compared, the Margin of Exposure was 137.</div><div>In conclusion, based on a WoE approach, the concentrations of AVO used in cosmetic products are not expected to carry a risk of local irritation effects on the respiratory tract or add significantly to aggregate systemic exposure.</div></div>","PeriodicalId":20852,"journal":{"name":"Regulatory Toxicology and Pharmacology","volume":"162 ","pages":"Article 105905"},"PeriodicalIF":3.0000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regulatory Toxicology and Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0273230025001357","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, LEGAL","Score":null,"Total":0}
引用次数: 0
Abstract
Acetylated Vetiver Oil (AVO) is a fragrance ingredient. We evaluated the systemic and local toxicity of AVO via inhalation from use of cosmetic spray products.
Systemic exposure after inhalation was calculated using a deterministic 2-Box model. The “local inhalation toxicological threshold of concern” (TTCinh) was used in a weight of evidence (WoE) for the potential of AVO to cause local respiratory toxicity and the in vitro model, MucilAir™ was used to evaluate respiratory irritation.
AVO exposure by inhalation of sprayed cosmetic products does not add significant exposure compared to dermal exposure. The Margin of Safety (NOAEL compared to total systemic AVO exposure) is > 400, indicating no concern for systemic toxicity. Regarding local toxicity, total aggregate exposure to AVO in sprayable cosmetic products is significantly lower than the TTCinh. There were no injurious effects to MucilAir™ tissues by 0.2 % and 1 % AVO. When the NOAEL from the MucilAir™ assay (1 %) and the aggregated exposure were compared, the Margin of Exposure was 137.
In conclusion, based on a WoE approach, the concentrations of AVO used in cosmetic products are not expected to carry a risk of local irritation effects on the respiratory tract or add significantly to aggregate systemic exposure.
期刊介绍:
Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that are of direct importance and relevance for regulatory authorities with respect to toxicological and pharmacological regulations in society. All peer-reviewed articles that are published should be devoted to improve the protection of human health and environment. Reviews and discussions are welcomed that address legal and/or regulatory decisions with respect to risk assessment and management of toxicological and pharmacological compounds on a scientific basis. It addresses an international readership of scientists, risk assessors and managers, and other professionals active in the field of human and environmental health.
Types of peer-reviewed articles published:
-Original research articles of relevance for regulatory aspects covering aspects including, but not limited to:
1.Factors influencing human sensitivity
2.Exposure science related to risk assessment
3.Alternative toxicological test methods
4.Frameworks for evaluation and integration of data in regulatory evaluations
5.Harmonization across regulatory agencies
6.Read-across methods and evaluations
-Contemporary Reviews on policy related Research issues
-Letters to the Editor
-Guest Editorials (by Invitation)